Evidence map›Paper›PMID 28122622›Full record

Trial reportMalaria journal2017

Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial.

Ambrose O Talisuna, Amos Oburu, Sophie Githinji, Josephine Malinga, Beatrice Amboko, Philip Bejon, Caroline Jones, Robert W Snow, Dejan Zurovac

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ambrose O TalisunaKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Amos OburuKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Sophie GithinjiKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Josephine MalingaKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Beatrice AmbokoKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Philip BejonKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Caroline JonesKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Robert W SnowKEMRI-Welcome Trust Research Programme, Nairobi, Kenya.
Dejan ZurovacKEMRI-Welcome Trust Research Programme, Nairobi, Kenya. dzurovac@kemri-wellcome.org.ORCID 0000-0001-8267-9026

Funding

Medical Research Council MR/K007351/1Wellcome TrustWellcome Trust 079080Wellcome Trust 103602
6 · The paper itself

Abstract

backgroundShort Message Service (SMS) reminders have been suggested as a potential intervention for improving adherence to medications and health facility attendance.

methodsAn open-label, randomized, controlled trial to test the efficacy of automated SMS reminders in improving adherence to artemether-lumefantrine (AL) and post-treatment attendance in comparison with standard care was conducted at four health facilities in western Kenya. Children below five years of age with uncomplicated malaria were randomized to intervention (SMS reminders) or control groups. Within each study group they were further randomized to three categories, which determined the timing of home visits to measure adherence to complete AL course and to individual AL doses. A sub-set of caregivers was advised to return to the facility on day 3 and all were advised to return after 28 days. The primary outcomes were adherence to medication and return on day 3. The primary analysis was by intention-to-treat.

resultsBetween 9 June, 2014 and 26 February, 2016, 1677 children were enrolled. Of 562 children visited at home on day 3, all AL doses were completed for 97.6% (282/289) of children in the control and 97.8% (267/273) in the intervention group (OR = 1.10; 95% CI = 0.37-3.33; p = 0.860). When correct timing in taking each dose was considered a criteria for adherence, 72.3% (209/289) were adherent in the control and 69.2% (189/273) in the intervention group (OR = 0.82; 95% CI = 0.56-1.19; p = 0.302). Sending SMS reminders significantly increased odds of children returning to the facility on day 3 (81.4 vs 74.0%; OR = 1.55; 95% CI = 1.15-2.08; p = 0.004) and on day 28 (63.4 vs 52.5%; OR = 1.58; 95% CI = 1.30-1.92; p < 0.001).

conclusionsIn this efficacy trial, SMS reminders increased post-treatment return to the health facility, but had no effect on AL adherence which was high in both control and intervention groups. Further effectiveness studies under the real world conditions are needed to determine the optimum role of SMS reminders. Trial registration ISRCTN39512726.

Indexed as

Drug MonitoringAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsCaregiversChild, PreschoolDrug CombinationsEthanolaminesFemaleFluorenesHealth FacilitiesHumansInfantKenyaMalaria, FalciparumMaleAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsDrug CombinationsEthanolaminesFluorenesAdherenceArtemether–lumefantrineFollow-upSMS

Identifiers

PMID28122622
PMCPMC5267364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.